Patents Assigned to Catalent Pharma Solutions, LLC
  • Patent number: 11879009
    Abstract: The present invention relates to multifunctional protein molecules comprising decorin and uses thereof. In particular, the present invention relates to multifunctional protein molecules comprising decorin and a targeting polypeptide such as an antibody and methods of their production and uses thereof.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: January 23, 2024
    Assignee: CATALENT PHARMA SOLUTIONS, LLC
    Inventor: Gregory T. Bleck
  • Patent number: 11377488
    Abstract: The present invention relates to multifunctional protein molecules comprising decorin and uses thereof. In particular, the present invention relates to multifunctional protein molecules comprising decorin and a targeting polypeptide such as an antibody and methods of their production and uses thereof.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: July 5, 2022
    Assignee: CATALENT PHARMA SOLUTIONS, LLC
    Inventor: Gregory T. Bleck
  • Patent number: 10137168
    Abstract: The present invention relates to veterinary decorin compositions and methods of their production.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: November 27, 2018
    Assignee: CATALENT PHARMA SOLUTIONS, LLC
    Inventor: Gregory T. Bleck
  • Publication number: 20140315806
    Abstract: The present invention relates to veterinary decorin compositions and methods of their production.
    Type: Application
    Filed: April 22, 2014
    Publication date: October 23, 2014
    Applicant: CATALENT PHARMA SOLUTIONS, LLC
    Inventor: Gregory T. Bleck
  • Publication number: 20120238727
    Abstract: The present invention relates to improved decorin compositions and methods of their production.
    Type: Application
    Filed: March 13, 2012
    Publication date: September 20, 2012
    Applicant: CATALENT PHARMA SOLUTIONS LLC
    Inventors: Gregory Thomas Bleck, Ian John Collins, Mark Joseph Frey
  • Patent number: 8222188
    Abstract: The present invention relates to the production of antibody libraries. In particular, the present invention relates to the use of integrating retroviral vectors to generate libraries comprising a plurality of combinations of antibody light chains and heavy chains. The present invention thus provides improved methods of generating and screening antibody libraries comprising large numbers of unique antibodies.
    Type: Grant
    Filed: June 29, 2009
    Date of Patent: July 17, 2012
    Assignee: Catalent Pharma Solutions, LLC
    Inventors: Robert D. Bremel, Kurt Eakle, Michael Imboden